欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/1610/002
药品名称
Mirtazapine Bluefish 30 mg
活性成分
mirtazapine 30.0 mg
剂型
Orodispersible tablet
上市许可持有人
Bluefish Pharmaceuticals AB Sweden
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
Iceland (IS)
Denmark (DK)
Mirtazapin "Bluefish"
United Kingdom (Northern Ireland) (XI)
Ireland (IE)
Austria (AT)
Mirtazapin Bluefish 30 mg Schmelztabletten
Spain (ES)
Portugal (PT)
Norway (NO)
许可日期
2008/04/05
最近更新日期
2024/06/20
药物ATC编码
N06AX11 mirtazapine
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
Final SPC
|
m1-3-1-Mirtazapine Bluefish-clean-SPC
Date of last change:2014/02/28
Final PL
|
m1-3-1-Mirtazapine -Bluefish-clean-PIL
Date of last change:2014/02/28
Final Labelling
|
m1-3-1-Mirtazapine Bluefish-clean-Label
Date of last change:2014/02/28
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase